{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:30:08Z","timestamp":1776331808779,"version":"3.50.1"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Malignancies are found between the first three reasons of mortality in pediatric and adult kidney transplant recipients, who overall have disproportionately higher rates of cancer compared to the general population, including human papillomavirus (HPV)-related genital, anal and oropharynx region cancers. Therefore, preventing HPV in this patient population is extremely important. HPV-vaccine was demonstrated to prevent HPV infection in individuals with intact immune systems. In addition, recent data reported less precancerous HPV lesions and cervical cancers with use of HPV vaccine. Since HPV is a sexually transmitted virus that is typically acquired shortly after the onset of sexual activity, it is best to administer the HPV vaccine immunization prior to the onset of sexual activity. This article reviews the epidemiology and pathophysiology of the HPV infection, as well as its role in the development of HPV-related pre-cancerous lesions and cancers in both general population and kidney transplant recipients. The focus is on the most effective primary prophylactic strategy, which is the HPV vaccination. The particularities of HPV vaccination strategies in kidney transplant recipients are compared to the general population. In addition, the article analyzes the various causes of suboptimal HPV immunization rates in kidney transplant candidates and recipients and discusses vaccination optimization strategies that can be applied during childhood and adolescence to reduce the burden of HPV-related disease states and cancer among adult kidney transplant recipients.<\/jats:p>","DOI":"10.3389\/fped.2022.1057454","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T05:53:35Z","timestamp":1669787615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Human papillomavirus infection-related cancer risk for kidney transplant recipients during adult life can be reduced by vaccination during childhood and adolescence"],"prefix":"10.3389","volume":"10","author":[{"given":"Corina","family":"Nailescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia L.","family":"Shew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e13597","DOI":"10.1111\/petr.13597","article-title":"Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS","volume":"23","author":"Chua","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00467-020-04790-2","article-title":"Malignancies after pediatric solid organ transplantation","volume":"36","author":"Robinson","year":"2021","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamcollsurg.2017.04.012","article-title":"Post-Transplant malignancy after pediatric kidney transplantation: retrospective analysis of incidence and risk factors in 884 patients receiving transplants between 1963 and 2015 at the university of Minnesota","volume":"225","author":"Serrano","year":"2017","journal-title":"J Am Coll Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e14341","DOI":"10.1111\/petr.14341","article-title":"Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence","volume":"26","author":"Nailescu","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.critrevonc.2012.02.008","article-title":"HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients","volume":"84","author":"Hinten","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/ajt.15292","article-title":"Gynecologic cancers and solid organ transplantation","volume":"19","author":"Liao","year":"2019","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.urology.2020.06.077","article-title":"Risk of genitourinary malignancy in the renal transplant patient","volume":"145","author":"Jiang","year":"2020","journal-title":"Urology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1016\/j.vaccine.2020.05.004","article-title":"Effectiveness of \u201ccatch-up\u201d human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women","volume":"38","author":"Silverberg","year":"2020","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.36849\/JDD.6536","article-title":"Keratinocyte carcinomas in immunocompromised patients are reduced after administration of the nonavalent human papillomavirus vaccine","volume":"21","author":"Nichols","year":"2022","journal-title":"J Drugs in Dermatol: JDD"},{"key":"B11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.idc.2013.09.001","article-title":"HPV And HPV-associated diseases","volume":"27","author":"Dunne","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"B12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract & Res Clin Obstet & Gynaecol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/dc.24180","article-title":"Prevalence of high-risk HPV and atypia in liquid-based cytology of cervical and intra-anal specimens from kidney-transplanted women","volume":"47","author":"Eleut\u00e9rio","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canep.2015.01.010","article-title":"Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia","volume":"39","author":"Antonsson","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"ciac285","DOI":"10.1093\/cid\/ciac285","article-title":"Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls","author":"Larsen","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ygyno.2010.01.026","article-title":"Epidemiology and pathology of HPV disease in males","volume":"117","author":"Giuliano","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ajt.15056","article-title":"Risk of genital warts in renal transplant recipients-A registry-based, prospective cohort study","volume":"19","author":"Larsen","year":"2019","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jmv.23318","article-title":"Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens","volume":"84","author":"Komlos","year":"2012","journal-title":"J Med Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.anl.2015.03.006","article-title":"Molecular subtypification of human papillomavirus in Male adult individuals with recurrent respiratory papillomatosis","volume":"42","author":"Garc\u00eda-Romero","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"B24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/TP.0000000000003444","article-title":"Considerations for child cancer survivors and immunocompromised children to prevent secondary HPV-associated cancers","volume":"105","author":"Imburgia","year":"2021","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.pvr.2020.100202","article-title":"Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial","volume":"10","author":"Ferris","year":"2020","journal-title":"Papillomavirus Res (Amsterdam, Netherlands)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/v9100267","article-title":"Natural history of HPV infection across the lifespan: role of viral latency","volume":"9","author":"Gravitt","year":"2017","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/OLQ.0000000000001053","article-title":"Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young women","volume":"46","author":"El-Zein","year":"2019","journal-title":"Sex Transm Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1447-0756.2012.01977.x","article-title":"Human papillomavirus infection and the risk of cervical cancer in Japan","volume":"39","author":"Matsumoto","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"E259","DOI":"10.15167\/2421-4248\/jpmh2017.58.4.804","article-title":"Cervical human papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study","volume":"58","author":"Orlando","year":"2017","journal-title":"J Prev Med Hyg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/LGT.0000000000000414","article-title":"Cervical cytology and histology after solid organ transplant: a longitudinal cohort study","volume":"22","author":"Long","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.transproceed.2009.03.015","article-title":"Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data","volume":"41","author":"Veroux","year":"2009","journal-title":"Transplant Proc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1128\/JCM.38.6.2087-2096.2000","article-title":"Bouwes bavinck JN, ter schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients","volume":"38","author":"Berkhout","year":"2000","journal-title":"J Clin Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1743-422X-9-117","article-title":"Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study","volume":"9","author":"Pietrzak","year":"2012","journal-title":"Virol J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/infdis\/jiz614","article-title":"Anal squamous intraepithelial lesions (SILs) in human immunodeficiency virus-positive men who have sex with men: incidence and risk factors of SIL and of progression and clearance of low-grade SILs","volume":"222","author":"Jongen","year":"2020","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/01.tp.0000231706.79165.e5","article-title":"Human papillomavirus in the oral cavity of patients with and without renal transplantation","volume":"82","author":"Rose","year":"2006","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e12894","DOI":"10.1111\/ctr.12894","article-title":"Cervical human papillomavirus infection in the early postoperative period after liver transplantation: prevalence, risk factors, and concordance with anal infections","volume":"31","author":"Gr\u0105t","year":"2017","journal-title":"Clin Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0262724","DOI":"10.1371\/journal.pone.0262724","article-title":"Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in sao paulo, Brazil","volume":"17","author":"Miyaji","year":"2022","journal-title":"PloS one"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","article-title":"Efficacy and safety of prophylactic HPV vaccines. A cochrane review of randomized trials","volume":"17","author":"Arbyn","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"Jama"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: wHO position paper, may 2017-recommendations","volume":"35","year":"2017","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4161\/hv.7.2.13948","article-title":"The humoral response to gardasil over four years as defined by total IgG and competitive luminex immunoassay","volume":"7","author":"Brown","year":"2011","journal-title":"Hum Vaccin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/cid\/cix455","article-title":"Declines in human papillomavirus (HPV)-associated high-grade cervical lesions after Introduction of HPV vaccines in Connecticut, United States, 2008-2015","volume":"65","author":"Niccolai","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV Vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"105168","DOI":"10.1016\/j.oraloncology.2020.105168","article-title":"Human papilloma virus vaccine and prevention of head and neck cancer, what is the current evidence?","volume":"115","author":"Diana","year":"2021","journal-title":"Oral Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1080\/21645515.2021.1996809","article-title":"Discussing HPV and oropharyngeal cancer in dental settings: gender and provider-type matter","volume":"17","author":"Daley","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B46","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2013advisory committee on immunization practices (ACIP), 2011","volume":"60","year":"2011","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1016\/j.vaccine.2016.08.020","article-title":"Early impact of Ontario's Human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment","volume":"34","author":"Guerra","year":"2016","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1471-0528.2002.01053.x","article-title":"High incidence of cervical human papillomavirus infection in women during their first sexual relationship","volume":"109","author":"Collins","year":"2002","journal-title":"BJOG: an Int J Obstet and Gynaecol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamapediatrics.2019.0458","article-title":"Prevalence of sexual initiation before age 13 years among Male adolescents and young adults in the United States","volume":"173","author":"Lindberg","year":"2019","journal-title":"JAMA Pediatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.jogc.2018.05.024","article-title":"A review of the impact and effectiveness of the quadrivalent human papillomavirus vaccine: 10 years of clinical experience in Canada","volume":"40","author":"Steben","year":"2018","journal-title":"J Obstet and Gynaecol Can: JOGC"},{"key":"B51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1002\/cam4.1155","article-title":"Ten-year immune persistence and safety of the HPV-16\/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age","volume":"6","author":"Schwarz","year":"2017","journal-title":"Cancer Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S1473-3099(20)30873-2","article-title":"Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials","volume":"21","author":"Mariz","year":"2021","journal-title":"The Lancet Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.vaccine.2020.02.075","article-title":"Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV","volume":"38","author":"McClymont","year":"2020","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/cid\/ciy575","article-title":"The efficacy of the quadrivalent human papillomavirus vaccine in girls and women living with human immunodeficiency virus","volume":"68","author":"McClymont","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jdcr.2022.02.004","article-title":"Systemic 9-valent human papillomavirus vaccine for recalcitrant common cutaneous warts in preparation for renal transplant","volume":"22","author":"Wyant","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ajd.12684","article-title":"A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (gardasil) vaccination","volume":"59","author":"Maor","year":"2018","journal-title":"Australas J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","article-title":"HPV Vaccination of immunocompromised hosts","volume":"4","author":"Garland","year":"2017","journal-title":"Papillomavirus Res (Amsterdam, Netherlands)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fped.2020.00046","article-title":"Human papillomavirus vaccination in Male and female adolescents before and after kidney transplantation: a pediatric nephrology research consortium study","volume":"8","author":"Nailescu","year":"2020","journal-title":"Front Pediatr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1093\/cid\/ciaa1897","article-title":"Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV)","volume":"73","author":"Boey","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2215\/CJN.09690915","article-title":"Immunogenicity of human papillomavirus recombinant vaccine in children with CKD","volume":"11","author":"Nelson","year":"2016","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e13590","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1016\/j.vaccine.2019.07.072","article-title":"Long term follow up of persistence of immunity following quadrivalent human papillomavirus (HPV) vaccine in immunocompromised children","volume":"37","author":"MacIntyre","year":"2019","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00467-018-3953-z","article-title":"Vaccinations in pediatric kidney transplant recipients","volume":"34","author":"Fox","year":"2019","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4161\/hv.6.9.12730","article-title":"HPV Vaccine acceptance, utilization and expected impacts in the U.S.: where are we now?","volume":"6","author":"Dempsey","year":"2010","journal-title":"Hum Vaccin"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1016\/j.vaccine.2014.05.035","article-title":"Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons","volume":"32","author":"Donahue","year":"2014","journal-title":"Vaccine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s11764-019-00791-9","article-title":"Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer","volume":"13","author":"Castellino","year":"2019","journal-title":"J Cancer Surviv: Res and Practice"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00467-013-2502-z","article-title":"Growth and maturation improvement in children on renal replacement therapy over the past 20 years","volume":"28","author":"Franke","year":"2013","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1016\/j.vaccine.2020.06.074","article-title":"Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US","volume":"38","author":"Szilagyi","year":"2020","journal-title":"Vaccine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1016\/j.rcsop.2021","article-title":"Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates","volume":"2","author":"Teeter","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07448481.2021.1965146","article-title":"Strategies to improve human papillomavirus (HPV) vaccination rates among college students","author":"Kessler","year":"2021","journal-title":"J Am College Health: J of ACH"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e20192737","DOI":"10.1542\/peds.2019-2737","article-title":"Improving HPV vaccination rates: a stepped-wedge randomized trial","volume":"146","author":"Perkins","year":"2020","journal-title":"Pediatr"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e20192737","DOI":"10.1542\/peds.2018-1457","article-title":"An educational intervention to improve HPV vaccination: a cluster randomized trial","volume":"143","author":"Dixon","year":"2019","journal-title":"Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1057454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T05:53:39Z","timestamp":1669787619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1057454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":76,"alternative-id":["10.3389\/fped.2022.1057454"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1057454","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"article-number":"1057454"}}